Marion E. Andrew

1.1k total citations
27 papers, 920 citations indexed

About

Marion E. Andrew is a scholar working on Genetics, Epidemiology and Infectious Diseases. According to data from OpenAlex, Marion E. Andrew has authored 27 papers receiving a total of 920 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 11 papers in Epidemiology and 9 papers in Infectious Diseases. Recurrent topics in Marion E. Andrew's work include Virus-based gene therapy research (15 papers), Animal Virus Infections Studies (7 papers) and Poxvirus research and outbreaks (7 papers). Marion E. Andrew is often cited by papers focused on Virus-based gene therapy research (15 papers), Animal Virus Infections Studies (7 papers) and Poxvirus research and outbreaks (7 papers). Marion E. Andrew collaborates with scholars based in Australia, New Zealand and Canada. Marion E. Andrew's co-authors include Barbara E.H. Coupar, David B. Boyle, Gerald W. Both, Ian A. Ramshaw, Susan M. Phillips, Zélia Inês Portela Lobato, Terri E. O’Neil, John W. Lowenthal, A.R. Bellamy and R. V. Blanden and has published in prestigious journals such as Nature, Immunological Reviews and European Journal of Immunology.

In The Last Decade

Marion E. Andrew

27 papers receiving 886 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marion E. Andrew Australia 16 359 308 284 282 230 27 920
L. D. Miller United States 14 411 1.1× 238 0.8× 342 1.2× 390 1.4× 122 0.5× 36 1.2k
J. Brinkhof Netherlands 19 468 1.3× 233 0.8× 166 0.6× 153 0.5× 146 0.6× 36 1.0k
D. van Zaane Netherlands 16 304 0.8× 243 0.8× 189 0.7× 254 0.9× 142 0.6× 19 1.1k
Stephen Dunham United Kingdom 18 508 1.4× 254 0.8× 268 0.9× 193 0.7× 173 0.8× 42 1.0k
Patricia Whitaker‐Dowling United States 23 589 1.6× 274 0.9× 310 1.1× 429 1.5× 129 0.6× 51 1.3k
Oskar‐Rüger Kaaden Germany 15 320 0.9× 301 1.0× 125 0.4× 135 0.5× 75 0.3× 24 716
Randall W. Renshaw United States 20 397 1.1× 576 1.9× 103 0.4× 284 1.0× 130 0.6× 39 1.2k
J. Norman Flynn United Kingdom 21 631 1.8× 184 0.6× 242 0.9× 322 1.1× 500 2.2× 40 997
Masuyo Nakai Japan 20 477 1.3× 532 1.7× 527 1.9× 130 0.5× 863 3.8× 55 1.4k
Astrid Gall United Kingdom 17 412 1.1× 419 1.4× 121 0.4× 173 0.6× 199 0.9× 31 1.0k

Countries citing papers authored by Marion E. Andrew

Since Specialization
Citations

This map shows the geographic impact of Marion E. Andrew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion E. Andrew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion E. Andrew more than expected).

Fields of papers citing papers by Marion E. Andrew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marion E. Andrew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion E. Andrew. The network helps show where Marion E. Andrew may publish in the future.

Co-authorship network of co-authors of Marion E. Andrew

This figure shows the co-authorship network connecting the top 25 collaborators of Marion E. Andrew. A scholar is included among the top collaborators of Marion E. Andrew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marion E. Andrew. Marion E. Andrew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morris, Kirsten R., Andrew G. D. Bean, Matthew P. Bruce, et al.. (2008). Administration of Porcine Interleukin-3 Induces Increased Levels of Blood Eosinophils. Journal of Interferon & Cytokine Research. 28(7). 435–444. 4 indexed citations
2.
Andrew, Marion E., et al.. (2007). Sustained biological effects of porcine interleukin 5 delivered to pigs as recombinant protein or via a DNA vector. Cytokine. 40(3). 193–200. 4 indexed citations
3.
Middleton, Deborah, John Bingham, Paul Selleck, et al.. (2006). Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks. Virology. 359(1). 66–71. 54 indexed citations
4.
Tachedjian, Mary, et al.. (2003). Gene gun immunization in a preclinical model is enhanced by B7 targeting. Vaccine. 21(21-22). 2900–2905. 24 indexed citations
5.
Hammond, J. M., Elisa S. Jansen, C. Morrissy, et al.. (2001). A prime-boost vaccination strategy using naked DNA followed by recombinant porcine adenovirus protects pigs from classical swine fever. Veterinary Microbiology. 80(2). 101–119. 34 indexed citations
6.
Lowenthal, John W., et al.. (1999). Cytokine therapy: a natural alternative for disease control. Veterinary Immunology and Immunopathology. 72(1-2). 183–188. 37 indexed citations
7.
Andrew, Marion E.. (1998). The use of lectin-dependent lysis for detection of cytotoxic T lymphocytes in outbred animals. Journal of Immunological Methods. 213(1). 103–107. 2 indexed citations
8.
Lowenthal, John W., Terri E. O’Neil, Mary M. Broadway, et al.. (1998). Coadministration of IFN-γ Enhances Antibody Responses in Chickens. Journal of Interferon & Cytokine Research. 18(8). 617–622. 49 indexed citations
9.
Lobato, Zélia Inês Portela, Barbara E.H. Coupar, C. Gray, Ross Lunt, & Marion E. Andrew. (1997). Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens. Veterinary Immunology and Immunopathology. 59(3-4). 293–309. 53 indexed citations
10.
Andrew, Marion E., Pam Whiteley, Vijaya Janardhana, et al.. (1995). Antigen specificity of the ovine cytotoxic T lymphocyte response to bluetongue virus. Veterinary Immunology and Immunopathology. 47(3-4). 311–322. 55 indexed citations
11.
Offit, Paul A., Barbara E.H. Coupar, Roger Jenkins, et al.. (1994). Induction of Rotavirus-Specific Cytotoxic T Lymphocytes by Vaccinia Virus Recombinants Expressing Individual Rotavirus Genes. Virology. 198(1). 10–16. 21 indexed citations
12.
Janardhana, Vijaya, Marion E. Andrew, Sandra H. Thomas, & Barbara E.H. Coupar. (1994). Recombinant vaccinia viruses expressing interleukin‐5 stimulate an earlier appearance of antibody‐secreting cells in the lung. European Journal of Immunology. 24(9). 2266–2269. 4 indexed citations
13.
14.
Andrew, Marion E. & Barbara E.H. Coupar. (1992). Biological effects of recombinant vaccinia virus-expressed interleukin 4. Cytokine. 4(4). 281–286. 20 indexed citations
15.
Andrew, Marion E., et al.. (1992). Vaccinia—rotavirus VP7 recombinants protect mice against rotavirus-induced diarrhoea. Vaccine. 10(3). 185–191. 31 indexed citations
16.
Andrew, Marion E., Gunasegaran Karupiah, David B. Boyle, et al.. (1991). Effects of vaccinia virus-expressed interleukin 2 on the immune system of sublethally irradiated mice. Microbial Pathogenesis. 10(5). 363–371. 2 indexed citations
17.
Karupiah, Gunasegaran, Barbara E.H. Coupar, Ian A. Ramshaw, et al.. (1990). Vaccinia virus‐mediated damage of murine ovaries and protection by virus‐expressed interleukin‐2. Immunology and Cell Biology. 68(5). 325–333. 33 indexed citations
18.
Coupar, Barbara E.H., et al.. (1988). A general method for the construction of recombinant vaccinia viruses expressing multiple foreign genes. Gene. 68(1). 1–10. 60 indexed citations
19.
Andrew, Marion E., Barbara E.H. Coupar, David B. Boyle, & R. V. Blanden. (1987). Recognition by major histocompatibility complex class I‐restricted cytolytic T lymphocytes of cells expressing vaccinia‐encoded viral and class I proteins. European Journal of Immunology. 17(10). 1515–1518. 14 indexed citations
20.
Ramshaw, Ian A., Marion E. Andrew, Susan M. Phillips, David B. Boyle, & Barbara E.H. Coupar. (1987). Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection. Nature. 329(6139). 545–546. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. D. Miller Breakdown of academic impact, for papers by J. Brinkhof Breakdown of academic impact, for papers by D. van Zaane Breakdown of academic impact, for papers by Stephen Dunham Breakdown of academic impact, for papers by Patricia Whitaker‐Dowling Breakdown of academic impact, for papers by Oskar‐Rüger Kaaden Breakdown of academic impact, for papers by Randall W. Renshaw Breakdown of academic impact, for papers by J. Norman Flynn Breakdown of academic impact, for papers by Masuyo Nakai Breakdown of academic impact, for papers by Astrid Gall
Rankless by CCL
2026